Antimicrobial resistance and characterization of Helicobacter pylori strains isolated from Mexican adults with clinical outcome

被引:14
作者
Chihu, L
Ayala, G
Mohar, A
Hernández, A
Herrera-Goepfert, R
Fierros, G
González-Márquez, H
Silva, J
机构
[1] NCI, SSA, Mexico City, DF, Mexico
[2] Univ Autonoma Metropolitana Iztapalapa, Expt PhD Program, Mexico City 09340, DF, Mexico
[3] Univ Autonoma Metropolitana Iztapalapa, Dept Hlth Sci, Mexico City, DF, Mexico
[4] Natl Inst Publ Hlth, SSA, Cuernavaca, Morelos, Mexico
关键词
antimicrobial resistance; Helicobacter pylori; metronidazole; clarithromycin; amoxicillin; gastric diseases; virulence factors;
D O I
10.1179/joc.2005.17.3.270
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Eradication of Helicobacter pylori infection in Mexico is of great importance due to the elevated seroprevalence, however, there is yet very little information about antibiotic resistance rates in H. pylori isolates in our country. We analyzed susceptibility to three antimicrobials used in therapy of 49 H. pylori strains isolated from patients with active chronic gastritis, active chronic gastritis with lymphoid follicles, intestinal metaplasia and gastric cancer. All isolated strains were susceptible to amoxicillin, 28 (58%) were resistant to metronidazole and 2 (4%) were resistant to both clarithromycin and metronidazole. Sequence analysis of the 23S rRNA of the two clarithromycin-resistant strains showed the A2142G mutation in one and A2143G and T2182C mutations in the other. Metronidazole resistance was associated with cagA negative strains with a frequency of 82% (9/11). No significant correlation was found between vacA s/m alleles and metronidazole resistance.
引用
收藏
页码:270 / 276
页数:7
相关论文
共 37 条
[1]   Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole, and amoxicillin -: Influence on treatment outcome [J].
Adamek, RJ ;
Suerbaum, S ;
Pfaffenbach, B ;
Opferkuch, W .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1998, 93 (03) :386-389
[2]  
[Anonymous], IARC MONOGR EVAL CAR
[3]   MOSAICISM IN VACUOLATING CYTOTOXIN ALLELES OF HELICOBACTER-PYLORI - ASSOCIATION OF SPECIFIC VACA TYPES WITH CYTOTOXIN PRODUCTION AND PEPTIC-ULCERATION [J].
ATHERTON, JC ;
CAO, P ;
PEEK, RM ;
TUMMURU, MKR ;
BLASER, MJ ;
COVER, TL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (30) :17771-17777
[4]   Epidemiological features of Helicobacter pylori infection in developing countries [J].
Bardhan, PK .
CLINICAL INFECTIOUS DISEASES, 1997, 25 (05) :973-978
[5]  
Bazzoli F, 2001, EUR J GASTROEN HEPAT, V13, pS3
[6]   cagA status and eradication treatment outcome of anti-Helicobacter pylori triple therapies in patients with nonulcer dyspepsia [J].
Broutet, N ;
Marais, A ;
Lamouliatte, H ;
De Mascarel, A ;
Samoyeau, R ;
Salamon, R ;
Mégraud, F .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (04) :1319-1322
[7]   Performance criteria of DNA fingerprinting methods for typing of Helicobacter pylori isolates:: Experimental results and meta-analysis [J].
Burucoa, C ;
Lhomme, V ;
Fauchere, JL .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (12) :4071-4080
[8]   Regular review -: Treatment of Helicobacter pylori infection [J].
de Boer, WA ;
Tytgat, GNJ .
BRITISH MEDICAL JOURNAL, 2000, 320 (7226) :31-34
[9]   Guidelines on the management of H-pylori in primary care:: development of an implementation strategy [J].
de Wit, NJ ;
Mendive, J ;
Seifert, B ;
Cardin, F ;
Rubin, G .
FAMILY PRACTICE, 2000, 17 :S27-S32
[10]   Characteristics of clinical Helicobacter pylori strains from Ecuador [J].
Debets-Ossenkopp, YJ ;
Reyes, G ;
Mulder, J ;
aan de Stegge, BM ;
Peters, JTAM ;
Savelkoul, PHM ;
Tanca, J ;
Peña, AS ;
Vandenbroucke-Grauls, CMJE .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (01) :141-145